REFERENCES
- Gurbuxani S, Vyas P, Crispino J D. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 2004; 103: 399–406
- Concolino D, Pascuzzi A, Pietragalla E, Lia R, Canepa S, Strisciuglio P. High prevalence of isolated pericardial effusion in Down syndrome. Am J Med Genet A 2005; 132: 331–332
- Dinleyici E C, Ucar B, Kilic Z, Dogruel N, Yarar C. Pericardial effusion due to hypothyroidism in Down syndrome: report of four cases. Neuro Endocrinol Lett 2007; 28(2), [Epub]
- Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Sem Perinatol 1997; 21: 97–101
- Kusanagi Y, Ochi H, Matsubara K, Ito M. Hypereosinophilic syndrome in a trisomy 21 fetus. Obstet Gynaecol 1998; 92: 701–702
- Jones G R, Weaver M, Lang W E. Transient blastemia in phenotypically normal newborns. Am J Pediatr Hematol Oncol 1987; 9: 153–157
- Wienberg A G, Schiller G, Windmiller J. Neonatal leukamoid reaction. Am J Dis Child 1982; 136: 310
- Richards M, Welch J, Whatmore A, Readett D, Vora A J. Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down syndrome. Arch Dis Child Fetal Neonatal Ed 1998; 79: F215–F217
- Abe K, Kajii T, Niikawa N. Disomic homozygosity in 21 trisomic cells: a mechanism responsible for transient myeloproliferative syndrome. Hum Genet 1989; 82: 313–316
- Lorber BJ, Freeman SB, Hassold T, et al. Characterization and molecular analysis of nondisjunction in 18 cases of trisomy 21 and leukemia. Genes Chromosomes Cancer 1992; 4: 222–227
- Huret J L, Leonard C. Chromosome 21 and platelets: a gene dosage effect?. Clin Genet 1997; 51: 140–141
- Suda J, Eguchi M, Akiyama Y, et al. Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder. Blood 1987; 69: 508–512
- Strobelt N, Ghidini A, Locatelli A, Vergani P, Mariani S, Biondi A. Intrauterine diagnosis and management of transient myeloproliferative disorder. Am J Perinatol 1995; 2: 132–134
- Hirashima C, Eguchi Y, Kohmura Y, Minakami H, Sato I. Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down syndrome. J Obstet Gynaecol Res 2000; 26: 303–306
- Karandikar N J, Aquino D B, McKenna R W, Kroft S H. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome: an immunophenotypic analysis. Am J Clin Pathol 2001; 116: 204–210
- Hayashi Y, Eguchi M, Sugita K, et al. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down syndrome. Blood 1988; 72: 15–23
- Miller J McC, Sherrill M D, Hathaway W E. Thrombocythemia in the myeloproliferative disorder of Down's syndrome. Pediatrics 1967; 40: 847–850
- Ito E, Kasai M, Hayashi Y, et al. Expression of erythroid-specific genes in acute megakaryoblastic leukemia and transient myeloproliferative disorder in Down's syndrome. Br J Hematol 1995; 90: 607–614
- Harigae H. GATA transcription factors and hematological diseases. Tohoku J Exp Med 2006; 210: 1–9